TREATMENT OF ANEMIA RESISTANT TO CONVENTIONAL ERYTHROPOIETIN THERAPY WITH THYMOPENTIN IN HEMODIALYSIS-PATIENTS

被引：3
|
作者：
RAIOLA, P [1 ]
MANZO, M [1 ]
SAGGESE, A [1 ]
TOMASINO, G [1 ]
CICCHELLA, T [1 ]
RAMBALDI, M [1 ]
PISANO, M [1 ]
LIZZA, B [1 ]
PERNA, AF [1 ]
机构：
[1] UNIV NAPLES 2,SCH MED,DEPT PEDIAT,CHAIR NEPHROL,NAPLES,ITALY
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 1995年 / 10卷
关键词：
CHRONIC RENAL FAILURE; RESISTANT ANEMIA; ERYTHROPOIETIN; THYMOPENTIN;
D O I：
10.1093/ndt/10.supp6.48
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：48 / 50
页数：3
相关论文
共 50 条
  • [41] CBF AND OXYGEN-METABOLISM IN HEMODIALYSIS-PATIENTS - EFFECTS OF ANEMIA CORRECTION WITH RECOMBINANT HUMAN EPO
    HIRAKATA, H
    YAO, H
    OSATO, S
    IBAYASHI, S
    ONOYAMA, K
    OTSUKA, M
    ICHIYA, Y
    KUWABARA, Y
    MASUDA, Y
    FUJISHIMA, M
    AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (05): : F737 - F743
  • [42] Analysis of anemia relative deficiency of iron and erythropoietin in patients with chronic renal failure in hemodialysis
    de Souza, Gonalves Alessandra
    Gois e Silva, Livia Jordana
    Dias Soares, Juliana Mikaelly
    Dos Santos Silva, Diego Felipe
    NUTRICION CLINICA Y DIETETICA HOSPITALARIA, 2016, 36 (03): : 162 - 169
  • [43] INFLUENCE OF ERYTHROPOIETIN ON DIALYZER REUSE, HEPARIN NEED, AND UREA KINETICS IN MAINTENANCE HEMODIALYSIS-PATIENTS
    VEYS, N
    VANHOLDER, R
    DECUYPER, K
    RINGOIR, S
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (01) : 52 - 59
  • [44] Mortality risk in hemodialysis patients according to anemia control and erythropoietin dosing
    Santos, Paulo Roberto
    Mourao Melo, Antonio Danilo
    Brito Cortez Lima, Monique Marie
    Holanda Negreiros, Idalina Maria A.
    Miranda, Jessica Silva
    Pontes, Larissa Salles
    Rabelo, Guilherme Menezes
    Parente Viana, Ana Carolina
    Alexandrino, Mayara Teixeira
    Barros, Francisco Anderson
    Ramos Neto, Benjamin
    Brito, Alana Alcantara
    Costa, Anderson Da Silva
    HEMODIALYSIS INTERNATIONAL, 2011, 15 (04) : 493 - 500
  • [45] THE USE OF GENERIC AND SPECIFIC QUALITY-OF-LIFE MEASURES IN HEMODIALYSIS-PATIENTS TREATED WITH ERYTHROPOIETIN
    LAUPACIS, A
    WONG, C
    CHURCHILL, D
    CONTROLLED CLINICAL TRIALS, 1991, 12 (04): : S168 - S179
  • [46] Correction of copper deficiency improves erythropoietin unresponsiveness in hemodialysis patients with anemia
    Higuchi, Terumi
    Matsukawa, Yoshihiro
    Okada, Kazuyoshi
    Oikawa, Osamu
    Yamazaki, Toshio
    Ohnishi, Yoshihiko
    Fujita, Takayuki
    Fukuda, Noboru
    Soma, Masayoshi
    Matsumoto, Koichi
    INTERNAL MEDICINE, 2006, 45 (05) : 271 - 273
  • [47] ERYTHROPOIETIN TREATMENT AND PLASMA-LEVELS OF CORTICOTROPIN-RELEASING HORMONE, DELTA SLEEP-INDUCING PEPTIDE AND OPIOID-PEPTIDES IN HEMODIALYSIS-PATIENTS
    HEGBRANT, J
    THYSELL, H
    EKMAN, R
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1992, 26 (04): : 393 - 396
  • [48] EFFECT OF ERYTHROPOIETIN ON ISCHEMIA TOLERANCE IN ANEMIC HEMODIALYSIS-PATIENTS WITH CONFIRMED CORONARY-ARTERY DISEASE
    WIZEMANN, V
    KAUFMANN, J
    KRAMER, W
    NEPHRON, 1992, 62 (02): : 161 - 165
  • [49] COMPARATIVE CROSSOVER STUDY OF INTRAVENOUSLY AND SUBCUTANEOUSLY ADMINISTERED RECOMBINANT-HUMAN-ERYTHROPOIETIN IN HEMODIALYSIS-PATIENTS
    STEFFENSEN, G
    AUNSHOLT, NA
    AHLBOM, G
    BLOOD PURIFICATION, 1992, 10 (5-6) : 241 - 247
  • [50] LACK OF INFLUENCE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON PARATHYROID FUNCTION IN HEMODIALYSIS-PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
    LAI, YH
    TSAI, JC
    CHEN, HC
    GUH, JY
    HWANG, SJ
    TSAI, JH
    NEPHRON, 1995, 70 (02) : 223 - 228
12345